The effect of Dopamine receptor 2 (DRD2) SNP’s on dyskinesia is a point of contention in current literature, as some studies indicate an increased risk of developing dyskinesia [31,32,33], while others revealed a protective effect on the incidence of dyskinesia [34,35]. This evidence concerns the gene DRD2 and Dyskinesia.